Clinical Trials Browser

Completed × Observational × Neoplasm, Residual × Clear all

NCT05625971 2026-01-07

NIRVANA

Neoplasm, Residual, Neoplasms, Plasma Cell

NCT04679285 2025-12-23

FERTILAM

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT06730412 2025-12-04

Clear-HPVca

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Neoplasm, Residual

NCT03521596 2025-11-18

FIL_BIOWM

Waldenstrom Macroglobulinemia, Neoplasm, Residual

NCT06404593 2024-05-08

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT06000306 2023-08-22

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

Recurrence, Neoplasm, Residual

NCT05637580 2022-12-05

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

NCT02627261 2022-09-06

MMRD

Multiple Myeloma, Neoplasm, Residual

NCT02900625 2021-01-27

VMRDO

Neoplasm, Residual

NCT03788850 2020-08-27

FARDCC

Uterine Cervical Dysplasia, Neoplasm, Residual

NCT00339898 2019-12-17

Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma

Sarcoma, Ewing, Neoplasm, Residual

NCT02527447 2019-10-30

Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT03491033 2018-04-10

Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

Neoplasm, Residual

NCT03054883 2017-02-16

Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy

Neoplasm, Residual, Lymphoma, Mantle-Cell

NCT02714790 2016-03-23

LAM-MMR

GenitourinaryOther hematologic neoplasm

Wilms Tumor, Leukemia, Myeloid, Acute, Neoplasm, Residual